Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Devroe Eric received 72,981 Acrivon Therapeutics, Inc. shares as an award (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Devroe Eric (Chief Operating Officer) received 72,981 Acrivon Therapeutics, Inc. shares as an award, leaving 146,953 shares. Filed May 20, 2026 (Form 4).
- Awarded
- 72,981 shares
- Holding after
- 146,953 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Award | 72,981 | 146,953 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Devroe Eric
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Devroe Eric · Aug 20, 2026
- Form 4 · Devroe Eric · May 18, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026